TN HB2075The HOPE Treatment Act aims to improve access to clinical trials for patients in Tennessee. It makes changes to several sections of the Tennessee Code to streamline the process and encourage participation in these trials. This could provide more treatment options for patients with various health conditions.
Supporters of the HOPE Treatment Act argue that it opens new avenues for patients seeking innovative treatments through clinical trials. They believe this legislation will enhance healthcare options and potentially lead to breakthroughs in medical research within the state.
Critics of the HOPE Treatment Act may argue that it could prioritize clinical trials over established treatment protocols, potentially putting patients at risk. They may also express concerns about the adequacy of oversight and the ethical implications of expanding access to experimental treatments.
The sponsor of HB2075, Bryan Terry, is an anesthesiologist and owner of Middle Tennessee Anesthesia, which places him within the broader healthcare industry. The bill, which focuses on clinical trials and healthcare-related subjects such as prescription drugs and mental health, could indirectly relate to his professional field. While there is no direct overlap between his specific role in anesthesia and the bill's focus on clinical trials, his involvement in the healthcare industry could suggest a peripheral alignment. The potential for indirect benefits arises from the possibility of increased healthcare activity or funding that could benefit healthcare providers in general, including those in anesthesiology. However, there is no evidence that the bill directly impacts anesthesiology practices or that it would lead to a significant financial gain for the sponsor.
Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.
| Type | Description | Industry | Source |
|---|---|---|---|
| Occupation | Anesthesiologist | — | TN Legislature bio |
| Employer | Middle Tennessee Anesthesia | — | AI-researched |
| Business Owner | Owner of Middle Tennessee Anesthesia | — | AI-researched |
| Employer | MURFREESBORO ANESTHESIA GROUP | — | TN Ethics Commission |
| Employer | RENTAL PROPERTY | — | TN Ethics Commission |
| Employer | VANGUARD GROUP INVESTMENTS DIVIDENDS | Securities & Investment | TN Ethics Commission |
| Employer | CHARLES SCHWAB | Securities & Investment | TN Ethics Commission |
| Business Owner | MURFREESBORO ANESTHESIA GROUP GENERAL PARTNER from Jan 2000 to Apr 2024 | — | TN Ethics Commission |
| Asset | REAL ESTATE OKLAHOMA CITY, CLEVELAND COUNTY, OKLAHOMA | Real Estate | TN Ethics Commission |
| Asset | T ROWE PRICE COLLEGE SAVINGS PROGRAM, Spouse, and Minor Child | Education | TN Ethics Commission |
| Asset | VANGUARD COLLEGE SAVINGS PROGRAM, Spouse, and Minor Child | Securities & Investment | TN Ethics Commission |
| Asset | MURFREESBORO ANESTHESIA GROUP PA | — | TN Ethics Commission |
| Asset | VANGUARD BOND | Securities & Investment | TN Ethics Commission |
| Asset | REAL ESTATE SARASOTA, SARASOTA COUNTY, FLORIDA | Real Estate | TN Ethics Commission |
| Asset | VANGUARD INVESTMENTS | Securities & Investment | TN Ethics Commission |
| Occupation | Medicine, THEIR HEALTH | — | TN Ethics Commission |
| Occupation | Pharmacology, NOT ACTIVELY PRACTICING | — | TN Ethics Commission |
Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.
